Anti-CYP26A1

Anti-CYP26A1
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ELK-ES2095.50 50 µl - -

Fragen Sie uns nach der Lieferzeit

169,00 €
ELK-ES2095.100 100 µl - -

Fragen Sie uns nach der Lieferzeit

283,00 €
 
cytochrome P450 family 26 subfamily A member 1(CYP26A1) Homo sapiens This gene encodes a member... mehr
Produktinformationen "Anti-CYP26A1"
cytochrome P450 family 26 subfamily A member 1(CYP26A1) Homo sapiens This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein acts on retinoids, including all-trans-retinoic acid (RA), with both 4-hydroxylation and 18-hydroxylation activities. This enzyme regulates the cellular level of retinoic acid which is involved in regulation of gene expression in both embryonic and adult tissues. Two alternatively spliced transcript variants of this gene, which encode the distinct isoforms, have been reported. [provided by RefSeq, Jul 2008], Protein function: A cytochrome P450 monooxygenase involved in the metabolism of retinoates (RAs), the active metabolites of vitamin A, and critical signaling molecules in animals (PubMed:22020119, PubMed:9228017, PubMed:9716180). RAs exist as at least four different isomers: all- trans-RA (atRA), 9-cis-RA, 13-cis-RA, and 9,13-dicis-RA, where atRA is considered to be the biologically active isomer, although 9-cis-RA and 13-cis-RA also have activity (Probable). Catalyzes the hydroxylation of atRA primarily at C-4 and C-18, thereby contributing to the regulation of atRA homeostasis and signaling (PubMed:22020119, PubMed:9228017, PubMed:9716180). Hydroxylation of atRA limits its biological activity and initiates a degradative process leading to its eventual elimination (Probable). Involved in the convertion of atRA to all-trans-4-oxo-RA. Able to metabolize other RAs such as 9-cis, 13-cis and 9,13-di-cis RA (PubMed:9228017). Can oxidize all-trans-13,14- dihydroretinoate (DRA) to metabolites which could include all-trans-4- oxo-DRA, all-trans-4-hydroxy-DRA, all-trans-5,8-epoxy-DRA, and all- trans-18-hydroxy-DRA. May play a role in the oxidative metabolism of xenobiotics such as tazarotenic acid (PubMed:26937021). [The UniProt Consortium] Recommended dilutions: Western Blot: 1/500 - 1/2000. Immunofluorescence: 1/200 - 1/1000. ELISA: 1/20000. Not yet tested in other applications.. Cellular localization: Endoplasmic reticulum membrane , Peripheral membrane protein. Microsome membrane , Peripheral membrane protein.
Schlagworte: Anti-CYP26, Anti-CYP26A1, Anti-hP450RAI, Anti-Cytochrome P450RAI, Anti-Cytochrome P450 26A1, Anti-Retinoic acid 4-hydroxylase, Anti-Retinoic acid-metabolizing cytochrome, Anti-Cytochrome P450 retinoic acid-inactivating 1, CYP26A1 rabbit pAb
Hersteller: ELK Biotechnology
Hersteller-Nr: ES2095

Eigenschaften

Anwendung: WB, IF, ELISA
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse, rat
Immunogen: The antiserum was produced against synthesized peptide derived from human Cytochrome P450 26A1. AA range:251-300
MW: 56 kD
Format: Antiserum

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CYP26A1"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen